169 related articles for article (PubMed ID: 7641708)
1. In vivo DNA adduct formation by bisphenol A.
Atkinson A; Roy D
Environ Mol Mutagen; 1995; 26(1):60-6. PubMed ID: 7641708
[TBL] [Abstract][Full Text] [Related]
2. Examination of microsomal cytochrome P450-catalyzed in vitro activation of o-phenylphenol to DNA binding metabolite(s) by 32P-postlabeling technique.
Pathak DN; Roy D
Carcinogenesis; 1992 Sep; 13(9):1593-7. PubMed ID: 1394845
[TBL] [Abstract][Full Text] [Related]
3. Benzo[a]pyrene-7,8-quinone-3'-mononucleotide adduct standards for 32P postlabeling analyses: detection of benzo[a]pyrene-7,8-quinone-calf thymus DNA adducts.
Balu N; Padgett WT; Nelson GB; Lambert GR; Ross JA; Nesnow S
Anal Biochem; 2006 Aug; 355(2):213-23. PubMed ID: 16797471
[TBL] [Abstract][Full Text] [Related]
4. In vitro conversion of environmental estrogenic chemical bisphenol A to DNA binding metabolite(s).
Atkinson A; Roy D
Biochem Biophys Res Commun; 1995 May; 210(2):424-33. PubMed ID: 7755618
[TBL] [Abstract][Full Text] [Related]
5. Mass spectrometry investigation of DNA adduct formation from bisphenol A quinone metabolite and MCF-7 cell DNA.
Zhao H; Wei J; Xiang L; Cai Z
Talanta; 2018 May; 182():583-589. PubMed ID: 29501196
[TBL] [Abstract][Full Text] [Related]
6. In vitro DNA and dGMP adducts formation caused by ochratoxin A.
Obrecht-Pflumio S; Dirheimer G
Chem Biol Interact; 2000 Jun; 127(1):29-44. PubMed ID: 10903417
[TBL] [Abstract][Full Text] [Related]
7. DNA adduct formation by the anticancer drug ellipticine in rats determined by 32P postlabeling.
Stiborová M; Breuer A; Aimová D; Stiborová-Rupertová M; Wiessler M; Frei E
Int J Cancer; 2003 Dec; 107(6):885-90. PubMed ID: 14601046
[TBL] [Abstract][Full Text] [Related]
8. Microsomal and peroxidase activation of 4-hydroxy-tamoxifen to form DNA adducts: comparison with DNA adducts formed in Sprague-Dawley rats treated with tamoxifen.
Pathak DN; Pongracz K; Bodell WJ
Carcinogenesis; 1995 Jan; 16(1):11-5. PubMed ID: 7834794
[TBL] [Abstract][Full Text] [Related]
9. In vivo genotoxicity of sodium ortho-phenylphenol: phenylbenzoquinone is one of the DNA-binding metabolite(s) of sodium ortho-phenylphenol.
Pathak DN; Roy D
Mutat Res; 1993 Apr; 286(2):309-19. PubMed ID: 7681543
[TBL] [Abstract][Full Text] [Related]
10. Formation of DNA adducts by microsomal and peroxidase activation of p-cresol: role of quinone methide in DNA adduct formation.
Gaikwad NW; Bodell WJ
Chem Biol Interact; 2001 Dec; 138(3):217-29. PubMed ID: 11714480
[TBL] [Abstract][Full Text] [Related]
11. Horseradish peroxidase mediates DNA and deoxyguanosine 3'-monophosphate adduct formation in the presence of ochratoxin A.
Obrecht-Pflumio S; Dirheimer G
Arch Toxicol; 2001 Dec; 75(10):583-90. PubMed ID: 11808918
[TBL] [Abstract][Full Text] [Related]
12. Tamoxifen metabolic activation: comparison of DNA adducts formed by microsomal and chemical activation of tamoxifen and 4-hydroxytamoxifen with DNA adducts formed in vivo.
Moorthy B; Sriram P; Pathak DN; Bodell WJ; Randerath K
Cancer Res; 1996 Jan; 56(1):53-7. PubMed ID: 8548775
[TBL] [Abstract][Full Text] [Related]
13. Comparative 32P-postlabeling analysis of benzo[a]pyrene--DNA adducts formed in vitro upon activation of benzo[a]pyrene by human, rabbit and rodent liver microsomes.
Roggeband R; Wolterbeek AP; Rutten AA; Baan RA
Carcinogenesis; 1993 Sep; 14(9):1945-50. PubMed ID: 8403223
[TBL] [Abstract][Full Text] [Related]
14. DNA adduction by polychlorinated biphenyls: adducts derived from hepatic microsomal activation and from synthetic metabolites.
Pereg D; Robertson LW; Gupta RC
Chem Biol Interact; 2002 Feb; 139(2):129-44. PubMed ID: 11823002
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the formation of the major diethylstilbestrol-DNA adduct and some evidence of its structure.
Bhat HK; Han X; Gladek A; Liehr JG
Carcinogenesis; 1994 Oct; 15(10):2137-42. PubMed ID: 7955045
[TBL] [Abstract][Full Text] [Related]
16. DNA adduct formation by tamoxifen with rat and human liver microsomal activation systems.
Pathak DN; Bodell WJ
Carcinogenesis; 1994 Mar; 15(3):529-32. PubMed ID: 8118938
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and liquid chromatography/tandem mass spectrometric characterization of the adducts of bisphenol A o-quinone with glutathione and nucleotide monophosphates.
Qiu SX; Yang RZ; Gross ML
Chem Res Toxicol; 2004 Aug; 17(8):1038-46. PubMed ID: 15310235
[TBL] [Abstract][Full Text] [Related]
18. 32P-postlabeling analysis of benzo[a]pyrene-DNA adducts formed in vitro and in vivo.
Bodell WJ; Devanesan PD; Rogan EG; Cavalieri EL
Chem Res Toxicol; 1989; 2(5):312-5. PubMed ID: 2519823
[TBL] [Abstract][Full Text] [Related]
19. Rat microsomes activating the anticancer drug ellipticine to species covalently binding to deoxyguanosine in DNA are a suitable model mimicking ellipticine bioactivation in humans.
Stiborová M; Stiborová-Rupertová M; Borek-Dohalská L; Wiessler M; Frei E
Chem Res Toxicol; 2003 Jan; 16(1):38-47. PubMed ID: 12693029
[TBL] [Abstract][Full Text] [Related]
20. A novel method for the isolation and identification of stable DNA adducts formed by Dibenzo[a,l]pyrene and Dibenzo[a,l]pyrene 11, 12-dihydrodiol 13,14-epoxides in vitro.
Devanesan P; Ariese F; Jankowiak R; Small GJ; Rogan EG; Cavalieri EL
Chem Res Toxicol; 1999 Sep; 12(9):796-801. PubMed ID: 10490500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
